Danish biotech developing novel treatments for Atrial Fibrillation
Acesion Pharma is a leading pharmaceutical manufacturing company dedicated to developing innovative treatments for atrial fibrillation (AF). With a strong focus on improving patient outcomes, Acesion Pharma leverages cutting-edge research and development to create more efficacious and safer drugs. The company's scientific foundation is rooted in the novel concept of treating AF by inhibiting SK channels, a promising target for developing improved treatment of AF.
Acesion Pharma is committed to advancing the field of cardiac arrhythmia treatment through selective drug molecules that regulate cardiac rhythm. Located at Ole Maaløes Vej 3, Copenhagen, Capital Region 2200, DK, Acesion Pharma is strategically positioned to drive innovation and excellence in the pharmaceutical industry. Acesion Pharma aims to provide healthcare professionals and patients with advanced therapeutic options.
Acesion Pharma continues to expand its research and development efforts, solidifying its position as a key player in the pharmaceutical sector. Acesion Pharma is dedicated to making a significant impact on the lives of individuals affected by atrial fibrillation. We invite the manager of Acesion Pharma to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence.
Acesion Pharma er en førende medicinalvirksomhed, der er dedikeret til at udvikle innovative behandlinger for atrieflimren (AF). Med et stærkt fokus på at forbedre patientresultaterne udnytter Acesion Pharma banebrydende forskning og udvikling til at skabe mere effektive og sikrere lægemidler. Virksomhedens videnskabelige grundlag er rodfæstet i det nye koncept om at behandle AF ved at hæmme SK-kanaler, et lovende mål for udvikling af forbedret behandling af AF.
Acesion Pharma er forpligtet til at fremme området for behandling af hjertearytmi gennem selektive lægemiddelmolekyler, der regulerer hjertets rytme. Beliggende på Ole Maaløes Vej 3, København, Capital Region 2200, DK, er Acesion Pharma strategisk positioneret til at drive innovation og ekspertise i medicinalindustrien. Acesion Pharma har til formål at give sundhedspersonale og patienter avancerede terapeutiske muligheder.
Acesion Pharma fortsætter med at udvide sin forsknings- og udviklingsindsats og styrker sin position som en nøglespiller i medicinalsektoren. Acesion Pharma er dedikeret til at gøre en væsentlig indvirkning på livet for personer, der er berørt af atrieflimren. Vi inviterer lederen af Acesion Pharma til at skabe et skræddersyet og eksklusivt firmashowcase og produktfortegnelse på vores platform for yderligere at forbedre deres markedstilstedeværelse.
Other organizations in the same industry
This company is also known as